Although decorin is regarded as the “endogenous guardian” and biglycan acts as a danger signal in cancer, asporin acts as an oncogene in some types of cancer (breast, pancreatic, colorectal, gastric, and prostate), but as a tumor suppressor gene in triple-negative breast cancer (75). This evidence concerns the gene DCN and triple-negative breast carcinoma.